Skin Manifestations in Adults with Gender Dysphoria on Hormone Treatment at Hospital de San José, Bogotá-Colombia

    December 2023 in “ International Journal of Dermatology ”
    Marco A. Castañeda, Henry Tovar, Nicolle G. Isaac, Consuelo Cárdenas
    Image of study
    TLDR Adults with gender dysphoria on hormone treatment often have skin problems like acne, which are common but not always recognized.
    The study titled "Skin manifestations in adults with gender dysphoria on hormone treatment in the outpatient clinic of Hospital de San José, Bogotá—Colombia" is an observational, descriptive, cross-sectional study that included 85 patients, predominantly young transgender men with an average age of 27 ± 9 years. The study found that skin manifestations secondary to hormone treatment in adults with gender dysphoria are frequent and often underdiagnosed. The main manifestation was acne (87%), followed by androgenetic alopecia and acanthosis nigricans. Transgender women presented more acne, androgenetic alopecia, hypertrichosis, seborrheic dermatitis, and melasma. The majority of patients received treatment, mainly topical therapies, and were treated by the endocrinology and dermatology services. The study concludes that these skin manifestations should be known and taken into account in the multidisciplinary approach to these patients, which should involve dermatologists.
    Discuss this study in the Community →

    Research cited in this study

    9 / 9 results

    Related Community Posts Join

    6 / 1000+ results

      community GT20029 China Phase II Trial For AGA Reached Primary Endpoint

      in Research/Science  134 upvotes 10 months ago
      The GT20029 tincture, a topical androgen receptor degrader, showed significant hair growth and good safety in a China Phase II trial for male androgenetic alopecia (AGA), with the 1% dose twice weekly identified as optimal. The company plans to initiate Phase III trials in China and Phase II in the U.S., and the treatment also shows promise for acne.

      community Androgenetic alopecia is a skin disease: DHT-mediated skin disorders

      in Research/Science  62 upvotes 1 year ago
      Dihydrotestosterone (DHT) impacts various skin conditions, including Androgenetic alopecia and seborrheic dermatitis, by causing overactivity in sebaceous glands. Topical medications Tacrolimus and Clobetasol can reduce these inflammatory conditions, and treatments like RU58841, Minoxidil, and Finasteride may also be beneficial.

      community Let's talk about natural options and last resorts.

      in Chat  7 upvotes 9 months ago
      The user discusses their long struggle with hair loss, considering various treatments like hair transplants, hair systems, and natural methods such as micro-needling, vitamin supplements, and a healthy lifestyle. They express concerns about side effects from drugs like finasteride and ultimately lean towards using a hair system for better appearance and confidence.

    Related Research

    5 / 5 results